Peter Baluk is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the area of targeted therapies. With a total of 4 patents to his name, Baluk's work focuses on advancing our understanding of angiogenesis and its implications for medical treatments.

Latest Patents

Among his latest patents, Baluk has developed cationic lipid compositions that specifically target angiogenic endothelial cells. These compositions utilize lipid/DNA complexes or cationic liposomes that can either inhibit or promote the growth of targeted cells. By administering cationic liposomes containing a detectable label, researchers can precisely locate sites of angiogenesis. The complexes may also include nucleotide constructs with promoters that are selectively activated in the environment of angiogenic endothelial cells.

Career Highlights

Peter Baluk is affiliated with the University of California, where he conducts his research and development. His work has been instrumental in exploring new therapeutic avenues for diseases related to abnormal blood vessel growth. His innovative approaches have garnered attention in the scientific community.

Collaborations

Baluk has collaborated with esteemed colleagues such as O Gavin Thurston and John McLean. These partnerships have further enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Peter Baluk's contributions to the field of biomedical research through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies targeting angiogenesis.